- 期刊
國際無菌藥品GMP修訂趨勢及國內無菌製劑廠符合現況之研析
Analysis on the Revision Trend of International Sterile Medical Products GMP and the Current Situation of Domestic Sterile Pharmaceutical Manufacturers
摘要
無菌藥品對於患者的用藥安全極具風險，因此除了一般的西藥藥品優良製造規範（Good Manufacturing Practice, GMP）要求以外，國際間對於無菌藥品的製造有更多額外規範，我國現行使用國際醫藥品稽查協約組織（Pharmaceutical Inspection Convention and Co-operation Scheme，PIC/S）GMP稽查標準的附則1即是針對無菌藥品的要求，2017年PIC/S組織公告修訂草案，內容已全面性修正，將對國內無菌製劑廠帶來衝擊；本研究透過問卷調查與實地診斷，探討新版法規上路時，業者可能遇到的問題，作為未來擬定業者輔導與訓練配套措施之參考，以期提升製藥水準，確保民眾用藥安全。
並列摘要
Sterile medical products are high risk to patients' safety. There are more good manufacturing practice (GMP) requirements for sterile medicine manufacturing compared to non-sterile medicinal products. In terms of GMP Guide for medical products published by the Pharmaceutical Inspection Convention and Co-operation Scheme (PIC/S), Annex 1 provides details for sterile products manufacturing. It is also the GMP standard used in Taiwan. In 2017, PIC/S has published a revised draft of Annex 1 for public consultation. There were significant changes in Annex 1, which would brought a great impact to the industry. Thus, through questionnaire and on-site analysis, this study explored the problems that manufactures may encounter. The results would be a useful information for the regulatory authority to prioritize the consultancy and resources to help the industry adapt to the new GMP requirements.
延伸閱讀
- 梁玉君、黃守賢、陳映樺、陳瑜絢、李明鑫（2016）。輸入藥品製造廠GMP實地查廠結果分析。食品藥物研究年報，(7)，285-294。https://www.airitilibrary.com/Article/Detail?DocID=22195718-201612-201701260015-201701260015-285-294
- 邱佳雯（2016）。政策變遷動力之研究-以食品GMP制度為例〔碩士論文，淡江大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0002-2108201616265300
- 傅淑卿、陳濬黌、陳映樺、王淑芬、李明鑫（2017）。輸入藥品製造廠GMP符合性－PMF書面審查案新措施成效分析研究。食品藥物研究年報，(8)，315-322。https://www.airitilibrary.com/Article/Detail?DocID=22195718-201711-201801120009-201801120009-315-322
- 洪文銓（2014）。Research on Mergers and Acquisitions Effect to Corporate Cultural Integration – a Case Study of International Pharmaceutical Company〔碩士論文，淡江大學〕。華藝線上圖書館。https://doi.org/10.6846/TKU.2014.00195
- 蔡巧彥（2021）。Analysis on Successful Commercialization Strategy of Biopharmaceuticals Development -- Development Center for Biotechnology as an Example〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU202103858